Cogent Biosciences COGT
NASDAQ COGT
$31.02 -0.57 (-1.80%)
At close: Oct 2, 2026 · 4:00 PM EDT

Cogent Biosciences (COGT) Return on Capital Employed [ROCE] (2018 - 2026)

Updated

Cogent Biosciences (COGT) posted Return on Capital Employed [ROCE] of -48.07% for Q2 2026, up 87.60 percentage points from -135.66% a year earlier but down 6.08 percentage points from the prior quarter.

Analysis

Cogent Biosciences (COGT) Return on Capital Employed [ROCE] (2018 - 2026) Analysis & Trends

For FY2025, Cogent Biosciences' Return on Capital Employed [ROCE] came in at -58.61%, up 45.54 percentage points from FY2024.

  • Annual Return on Capital Employed [ROCE] shows a five-year change of +1.36 percentage points (FY2020 to FY2025).
  • In prior years, Cogent Biosciences' Return on Capital Employed [ROCE] was -104.14% in FY2024 (-26.76 pp), -77.38% in FY2023 (-15.68 pp), -61.70% in FY2022 (-28.04 pp) and -33.66% in FY2021 (+26.30 pp).
  • Quarterly Return on Capital Employed [ROCE] has run from a low of -135.66% in Q2 2025 to a high of -29.90% in Q3 2021 over five years.
  • On a year-over-year basis, Return on Capital Employed [ROCE] has increased in each of the last three quarters, with an average year-over-year change of -0.09 percentage points over the last eight quarters.
  • The strongest year-over-year quarter for Return on Capital Employed [ROCE] in the past five years was Q2 2026, with a gain of 87.60 percentage points; the weakest was Q2 2025, with a drop of 76.44 percentage points.
  • According to Business Quant data, Return on Capital Employed [ROCE] for the three prior quarters was -41.98% (Q1 2026), -53.96% (Q4 2025) and -106.76% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROCE (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn 46.74%
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 17.83%
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn 17.92%
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn 6.28%
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn 19.32%
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn 9.54%
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn 16.66%
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn -5.97%
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn 11.86%
10 Cogent Biosciences 5.32 Bn 5.32 Bn - -48.07%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -48.07%
Mar 31, 2026 -41.98%
Dec 31, 2025 -53.96%
Sep 30, 2025 -106.76%
Jun 30, 2025 -135.66%
Mar 31, 2025 -112.45%
Dec 31, 2024 -91.90%
Sep 30, 2024 -73.58%
Jun 30, 2024 -59.22%
Mar 31, 2024 -63.48%
Dec 31, 2023 -70.25%
Sep 30, 2023 -57.09%
Jun 30, 2023 -56.58%
Mar 31, 2023 -61.20%
Dec 31, 2022 -51.10%
Sep 30, 2022 -39.89%
Jun 30, 2022 -43.56%
Mar 31, 2022 -46.71%
Dec 31, 2021 -36.56%
Sep 30, 2021 -29.90%
API Access

Cogent Biosciences Return on Capital Employed [ROCE] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=COGT&period=max&api_key=YOUR_API_KEY